Compositions and methods for rendering tumor cells susceptible to CD8+ T cell-mediated killing
US-10183985-B2 · Jan 22, 2019 · US
This page is not indexed by search engines while we improve data quality.
Patent family 50278722
This patent family groups 4 related publications across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 50278722 |
| Family type | — |
| Earliest priority | Sep 14, 2012 |
| First filing country | US |
| Member publications | 4 |
| Countries | US |
| Representative publication | US10183985B2 — Compositions and methods for rendering tumor cells susceptible to CD8+ T cell-mediated killing |
Representative publication
Best representative member for this family based on priority and filing country.
US10183985B2 — Compositions and methods for rendering tumor cells susceptible to CD8+ T cell-mediated killing (published Jan 22, 2019)
Member publications
Related publications in this family.
Compositions and methods for rendering tumor cells susceptible to cd8+ t cell-mediated killing
US-2017137493-A1 · May 18, 2017 · US
Compositions and methods for rendering tumor cells susceptible to CD8+ T cell-mediated killing
US-9561275-B2 · Feb 7, 2017 · US
Compositions and methods for rendering tumor cells susceptible to cd8+ t cell-mediated killing
US-2015231239-A1 · Aug 20, 2015 · US